BCAB
Price
$0.21
Change
+$0.02 (+10.53%)
Updated
Feb 4 closing price
Capitalization
13.23M
42 days until earnings call
Intraday BUY SELL Signals
LEGN
Price
$16.65
Change
-$0.01 (-0.06%)
Updated
Feb 4 closing price
Capitalization
3.07B
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAB vs LEGN

Header iconBCAB vs LEGN Comparison
Open Charts BCAB vs LEGNBanner chart's image
BioAtla
Price$0.21
Change+$0.02 (+10.53%)
Volume$1.8M
Capitalization13.23M
Legend Biotech
Price$16.65
Change-$0.01 (-0.06%)
Volume$1.9M
Capitalization3.07B
BCAB vs LEGN Comparison Chart in %
View a ticker or compare two or three
VS
BCAB vs. LEGN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and LEGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BCAB: $0.21 vs. LEGN: $16.65)
Brand notoriety: BCAB and LEGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 76% vs. LEGN: 71%
Market capitalization -- BCAB: $13.23M vs. LEGN: $3.07B
BCAB [@Biotechnology] is valued at $13.23M. LEGN’s [@Biotechnology] market capitalization is $3.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileLEGN’s FA Score has 1 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • LEGN’s FA Score: 1 green, 4 red.
According to our system of comparison, LEGN is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while LEGN’s TA Score has 4 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 4 bearish.
  • LEGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than LEGN.

Price Growth

BCAB (@Biotechnology) experienced а -32.40% price change this week, while LEGN (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

BCAB is expected to report earnings on Mar 19, 2026.

LEGN is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($3.07B) has a higher market cap than BCAB($13.2M). LEGN YTD gains are higher at: -23.413 vs. BCAB (-63.026). BCAB has higher annual earnings (EBITDA): -65.71M vs. LEGN (-176.13M). LEGN has more cash in the bank: 993M vs. BCAB (8.32M). BCAB has less debt than LEGN: BCAB (6.18M) vs LEGN (410M). LEGN has higher revenues than BCAB: LEGN (909M) vs BCAB (0).
BCABLEGNBCAB / LEGN
Capitalization13.2M3.07B0%
EBITDA-65.71M-176.13M37%
Gain YTD-63.026-23.413269%
P/E RatioN/AN/A-
Revenue0909M-
Total Cash8.32M993M1%
Total Debt6.18M410M2%
TECHNICAL ANALYSIS
Technical Analysis
BCABLEGN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 17 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signal:
Gain/Loss:
LEGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCBS29.830.57
+1.95%
MetroCity Bankshares
AGO87.091.29
+1.50%
Assured Guaranty Ltd
VTR77.730.04
+0.05%
Ventas
TAVI10.48N/A
N/A
Tavia Acquisition Corp.
HOTH0.80-0.04
-4.33%
Hoth Therapeutics

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been closely correlated with VTGN. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCAB jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+11.06%
VTGN - BCAB
82%
Closely correlated
-3.20%
QNCX - BCAB
80%
Closely correlated
+9.28%
CALC - BCAB
77%
Closely correlated
+8.37%
LENZ - BCAB
76%
Closely correlated
-5.86%
GNTA - BCAB
72%
Closely correlated
-1.27%
More

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been closely correlated with VTGN. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if LEGN jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-0.06%
VTGN - LEGN
82%
Closely correlated
-3.20%
QNCX - LEGN
79%
Closely correlated
+9.28%
RZLT - LEGN
75%
Closely correlated
-7.62%
CALC - LEGN
72%
Closely correlated
+8.37%
BCAB - LEGN
72%
Closely correlated
+11.06%
More